Initial public offerings scheduled to debut next week

NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT ( and SEC filings.

Week of January 27

Cara Therapeutics Inc. – Shelton, Conn., 5 million shares priced $11 to $13, managed by Stifel and Piper Jaffray. Proposed Nasdaq symbol CARA. Business: Clinical-stage biotech developing novel opioid pain medication.

Dicerna Pharmaceuticals Inc. – Watertown, Mass., 5 million shares, priced $11 to $13, managed by Jeffries, Leerink Partners, and Stifel. Proposed Nasdaq symbol DRNA. Business: Developing RNAi therapeutics for the treatment of liver disease and cancer.

Intrawest Resort Holdings Inc. – Denver, 15.6 million shares, priced $15 to $17, managed by Goldman Sachs, Credit Suisse, and Deutsche Bank. Proposed NYSE symbol SNOW. Business: A leading mountain resort and adventure company.

Malibu Boats Inc. – Loudon, Tenn., 7.1 million shares, priced $13 to $15, managed by Raymond James and Wells Fargo. Proposed Nasdaq symbol MBUU. Business: Leading performance sport boat manufacturer.

New Home Co. Inc. (The) – Aliso Viejo, Calif., 7.8 million shares, priced $15 to $17, managed by Citigroup, J.P. Morgan, and Credit Suisse. Proposed NYSE symbol NWHM. Business: Single-family homebuilder focused on major metropolitan areas in California.

Ultragenyx Phamaceutical Inc. – Novato, Calif., 4.8 million shares, priced $14 to $17, managed by J.P. Morgan and Morgan Stanley. Proposed Nasdaq symbol RARE. Business: Clinical-stage biotech developing treatments for rare metabolic genetic diseases.